Sunitinib Glenmark

Sunitinib Glenmark is an oral medication used for certain types of cancer. It belongs to a class of drugs that work by slowing or stopping cancer cell growth. This product is manufactured by Glenmark Pharmaceuticals S.R.O. and is available for oral use.

Sunitinib is prescribed to treat specific cancers, including gastrointestinal stromal tumors (GIST) and advanced renal cell carcinoma (RCC). It may also be used for pancreatic neuroendocrine tumors (pNET) in some cases. This medication helps manage symptoms and slow disease progression by targeting cancer cells.

Sunitinib may help reduce tumor size and alleviate symptoms related to cancer. Patients often experience improved energy levels and reduced pain as the medication works systemically. Common effects include fatigue, digestive changes, and skin discoloration.

Store Sunitinib in a cool, dry place away from direct sunlight. Keep it out of reach of children and pets. Avoid crushing or splitting tablets unless directed by a healthcare professional. Always follow the handling instructions provided with the medication.

Sunitinib may interact with other medications, including certain antibiotics, antifungals, and heart medications. Avoid grapefruit or grapefruit juice, as it can affect how the drug works. Consult a healthcare provider before combining with over-the-counter supplements or herbal products.